Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Neurology, Movement Disorders
Organization
School of Medicine
>
Clinical Science Departments
>
Neurology
>
Neurology, Movement Disorders
Overview
overview {hide_children: false, active: true, enabled: true}
Overview
people {hide_children: false, active: true, enabled: true}
People
Embed Organization Data
Embed Organization Data
Recent Scholarship
Scholars
8
Publications
262
Featured Publications
Mechanisms mediating dynamic changes in neural responses during deep brain stimulation.
Journal Article
Brain Stimul
·
December 10, 2025
Full text
Link to item
Cite
Long-Term Personalized Adaptive Deep Brain Stimulation in Parkinson Disease: A Nonrandomized Clinical Trial.
Journal Article
JAMA Neurol
·
November 1, 2025
Full text
Link to item
Cite
Huntington Disease and Chorea
Journal Article
Continuum
·
August 2025
Full text
Cite
Search More
Featured Grants
exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Participants With Parkinson's Disease
Clinical Trial
·
Awarded by BlueRock Therapeutics LP ·
2025 - 2032
A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS PRASINEZUMAB IN PARTICIPANTS WITH EARLY-STAGE PARKINSON'S DISEASE
Clinical Trial
·
Awarded by Genentech, Inc. ·
2025 - 2031
An open-label clinical trial investigating the long-term safety of buntanetap in treating participants with Parkinson's disease
Clinical Trial
·
Awarded by DCRI-Duke-Site ·
2026 - 2029
Biohaven BHV-8000
Clinical Trial
·
Awarded by Biohaven Pharmaceuticals ·
2025 - 2028
A Phase 2, Randomized, Double-Blind, Sham Surgery-controlled Study of the Efficacy and Safety of Intraputaminal AAV2-GDNF in the Treatment of Adults with Moderate Stage Parkinson's Disease
Clinical Trial
·
Awarded by Asklepios BioPharmaceutical, Inc. ·
2025 - 2028
Search More